This research highlights the metabolic effects of androgenic contraceptives, showing significant increases in postprandial glucose and insulin levels in women.
Merck says Keytruda improves survival before and after lung cancer surgery, awaits FDA decision next week
Merck announced Tuesday that patients with non-small cell lung cancer who received Keytruda before and after surgery lived longer than those who received a placebo